Peptide regulatory monitoring, on a published schedule.
The plan covers the FDA, HHS, DEA, FTC, USP, and every state medical and pharmacy board. Daily federal and PubMed schedules exist. This page does not prove those jobs have completed, and it does not prove a daily PDF already lands in Drive.
Four federal regulators. Fifty state boards in the plan.
The FDA writes the compounding rules. The DEA sets the controlled substance schedule. The FTC handles marketing enforcement. The USP writes the compounding chapters. Then every state has its own medical board and its own pharmacy board, and either one can discipline a prescriber. That is more than 100 sources. Daily federal and PubMed schedules exist. State board jobs are planned on a weekly cadence. This page does not prove those checks have run.
The monitoring register: 10 planned jobs
Two daily schedules exist: the federal scan that covers the FDA, DEA, FTC, and USP, and the PubMed literature scan. Completion is not proven on this page. The 50 state boards plus DC are planned weekly jobs. They are not a morning scan of every state.
| Regulator or scope | Cadence | What it watches | Threshold | Status |
|---|---|---|---|---|
| Federal regulatory scan | Daily, 7am ET | FDA 503A and 503B compounding lists, PCAC dockets, DEA scheduling and the Federal Register under the FDA, the DEA and the HHS Office of the Secretary, FTC marketing enforcement, and USP compounding chapters | Any peptide, compounding, or telemedicine change | Schedule exists |
| HHS and the Federal Register public inspection desk | Daily, 4pm and 4:30pm ET | Every FDA, HHS and DEA document the day it reaches the Federal Register public inspection desk, the HHS news feed, and the HHS peptide enforcement discretion policy file itself, checked for any edit | A filing naming 503A, 503B, compounding, bulk drug substances, a peptide or PCAC; any edit to the HHS policy | Schedule exists |
| PubMed peptide and biomarker literature scan | Daily, 7am ET | New peptide and biomarker studies as PubMed indexes them | A study that changes a peptide's use, dose, or caution | Schedule exists |
| State boards: Texas and California | Weekly | Texas Medical Board, Texas Pharmacy, Medical Board of California, and California Pharmacy | Peptide, telemedicine, or compounding action only | Weekly rollout planned |
| State boards: Northeast, 11 states | Weekly | Medical and pharmacy board news for CT, DE, ME, MD, MA, NH, NJ, NY, PA, RI, and VT | Peptide, telemedicine, or compounding action only | Weekly rollout planned |
| State boards: Southeast, 12 states | Weekly | Medical and pharmacy board news for AL, AR, FL, GA, KY, LA, MS, NC, SC, TN, VA, and WV | Peptide, telemedicine, or compounding action only | Weekly rollout planned |
| State boards: Midwest, 12 states | Weekly | Medical and pharmacy board news for IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI | Peptide, telemedicine, or compounding action only | Weekly rollout planned |
| State boards: West plus DC, 13 states and DC | Weekly | Medical and pharmacy board news for AK, AZ, CO, HI, ID, MT, NV, NM, OK, OR, UT, WA, WY, and DC | Peptide, telemedicine, or compounding action only | Weekly rollout planned |
Built to be quiet until it matters.
The planned output is a one page PDF to Drive.
The design is a short PDF in a shared Drive folder after a federal or PubMed run. If nothing changed, the PDF would say so and still list what was checked. This page does not prove a PDF has been written.
Threshold discipline.
We do not send noise. Routine state board discipline that has nothing to do with peptides does not trigger anything. The scan only flags peptide, compounding, and telemedicine signal.
Linked to your prescribing framework.
When a new study or ruling changes what a peptide should be prescribed for, or at what dose, or with what caution, we write a plain English delta note so you can update your protocol. This is the Sequence Method feedback loop.
What the daily PDF is meant to look like
A sample PDF will be linked here only after a completed run is proven. Schedules exist. Completion is not proven on this page.
Want to review the monitoring plan?
We only take a limited number of prescribers per quarter. Apply for early access.